PharmaShots | Incisive News in 3 Shots

Subscribe Now

astellas pharma

The NMPA Approves Astellas’ Padcev (Enfortumab vedotin) to Treat Adults with Advanced or Metastatic Urothelial Cancer

The NMPA Approves Astellas’ Padcev (Enfortumab vedotin) to Treat Adults with Advanced or Metastatic Urothelial Cancer

August 20, 2024

Astellas Receives the MHLW’s Priority Review for the sNDA Submitted for Padcev and Keytruda as Combination Therapy to Treat Bladder Cancer

Astellas Receives the MHLW’s Priority Review for the sNDA Submitted for Padcev and Keytruda as Combination Therapy to Treat Bladde...

February 16, 2024

Top 20 Immunology Companies Based on 2018 Immunology Segment Revenue

Top 20 Immunology Companies Based on 2018 Immunology Segment Revenue

August 9, 2019

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us